Stay updated on Nivolumab & Lenvatinib in HCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.

Latest updates to the Nivolumab & Lenvatinib in HCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing v3.6.4, indicating a site revision rather than a change to the study content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s revision label was updated to v3.6.4, indicating a new deployment of the page template. It does not alter study details or visible content.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3 in the footer, signaling a small maintenance release.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision changed from v3.6.0 to v3.6.2, indicating a newer version of the page was published. This typically reflects minor updates or fixes without altering the study data or key details.SummaryDifference0.1%

- Check69 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating that enrollment has ended. New sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, the Intervention / Treatment header was standardized to Intervention/Treatment, and a Revision: v3.6.0 note was added.SummaryDifference0.4%

- Check76 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. This reflects a minor platform update to the page rendering rather than changes to study data or content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & Lenvatinib in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.